scholarly article | Q13442814 |
P2093 | author name string | Bruce M McManus | |
Decheng Yang | |||
Honglin Luo | |||
Agripina Suarez | |||
Caroline Cheung | |||
Jingchun Zhang | |||
P2860 | cites work | A role for ubiquitin ligase recruitment in retrovirus release | Q24642874 |
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2 | Q24643016 | ||
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease | Q28343611 | ||
The ubiquitin-proteasome pathway and proteasome inhibitors | Q28367002 | ||
The ubiquitin-proteasome pathway: on protein death and cell life | Q29619270 | ||
Protein regulation by monoubiquitin | Q29620221 | ||
HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte | Q29620367 | ||
Proteasome inhibitors: valuable new tools for cell biologists | Q29620573 | ||
Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway | Q34333784 | ||
Viral infection and the pathogenesis of dilated cardiomyopathy | Q34348615 | ||
Development of the proteasome inhibitor PS-341. | Q34537877 | ||
A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line | Q35171318 | ||
Progress and challenges in the pathological diagnosis of myocarditis | Q36428835 | ||
Ubiquitin is part of the retrovirus budding machinery | Q37281238 | ||
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication | Q38306433 | ||
X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter | Q38531299 | ||
Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest | Q39698538 | ||
Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro | Q39752763 | ||
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis | Q39875225 | ||
Ubiquitin, proteasomes, and the regulation of intracellular protein degradation | Q40445002 | ||
Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest | Q40748304 | ||
Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activity | Q42818894 | ||
Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis | Q44002712 | ||
Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells. | Q54571909 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Coxsackievirus | Q1138287 |
P304 | page(s) | 381-385 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes | |
P478 | volume | 163 |
Q47547539 | A novel role of ER stress signal transducer ATF6 in regulating enterovirus A71 viral protein stability. |
Q34150998 | A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication |
Q36385481 | Autoimmunity in coxsackievirus B3 induced myocarditis |
Q36524801 | Broad and potent antiviral activity of the NAE inhibitor MLN4924. |
Q47315412 | Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication |
Q35732935 | Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function |
Q24630927 | Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century |
Q33326624 | Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication |
Q41161957 | Dysferlin deficiency confers increased susceptibility to coxsackievirus-induced cardiomyopathy |
Q42797471 | Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication |
Q34356945 | ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3β in the signal network |
Q36705558 | Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study. |
Q35544380 | Human Pirh2 is a novel inhibitor of prototype foamy virus replication |
Q33781261 | Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand |
Q37110640 | Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes |
Q51130109 | Modification of SARS-CoV S1 gene render expression in Pichia pastoris. |
Q37937617 | Multifaceted roles of curcumin: two sides of a coin! |
Q38728290 | Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53. |
Q35088241 | Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes |
Q36302442 | PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection |
Q34223177 | Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. |
Q59804795 | Proteasomal Protein Degradation: Adaptation of Cellular Proteolysis With Impact on Virus-and Cytokine-Mediated Damage of Heart Tissue During Myocarditis |
Q36080090 | Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells. |
Q34190751 | Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation |
Q39976598 | Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice |
Q39985514 | Proteasome inhibition reduces avian reovirus replication and apoptosis induction in cultured cells |
Q37541537 | Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy |
Q50025561 | Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response |
Q37036711 | Pyrrolidine dithiocarbamate inhibits herpes simplex virus 1 and 2 replication, and its activity may be mediated through dysregulation of the ubiquitin-proteasome system |
Q42847096 | Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway |
Q40097756 | Reduction of infectious bursal disease virus replication in cultured cells by proteasome inhibitors |
Q35531278 | Replication of the rotavirus genome requires an active ubiquitin-proteasome system |
Q43207997 | Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid |
Q92404517 | The Capsid Protein VP1 of Coxsackievirus B Induces Cell Cycle Arrest by Up-Regulating Heat Shock Protein 70 |
Q45373236 | The Ubiquitin-Proteasome System Regulates the Accumulation ofTurnip yellow mosaic virusRNA-Dependent RNA Polymerase during Viral Infection |
Q33855429 | The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling |
Q42738022 | The proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice. |
Q22242631 | The role of infections in autoimmune disease |
Q40543452 | The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice |
Q36538328 | The ubiquitin-proteasome pathway in viral infections |
Q38989110 | The ubiquitin-proteasome system is required for the early stages of porcine circovirus type 2 replication |
Q34190714 | Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism |
Q82753223 | Tripeptidyl peptidase II serves as an alternative to impaired proteasome to maintain viral growth in the host cells |
Q112033680 | Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis |
Q38115330 | Ubiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapy. |
Q33350188 | Ubiquitination is required for effective replication of coxsackievirus B3. |
Q38052447 | Viral myocarditis: from experimental models to molecular diagnosis in patients |
Q37333951 | Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period |
Q39902786 | West Nile virus genome amplification requires the functional activities of the proteasome |
Search more.